LifePlan Financial LLC Invests $1.50 Million in Medtronic plc (NYSE:MDT)

LifePlan Financial LLC acquired a new position in Medtronic plc (NYSE:MDT - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 18,173 shares of the medical technology company's stock, valued at approximately $1,497,000. Medtronic comprises approximately 1.5% of LifePlan Financial LLC's holdings, making the stock its 17th biggest holding.

Other large investors have also recently made changes to their positions in the company. Fortitude Family Office LLC bought a new stake in shares of Medtronic in the 4th quarter worth approximately $25,000. Hartford Financial Management Inc. boosted its position in shares of Medtronic by 425.0% during the third quarter. Hartford Financial Management Inc. now owns 315 shares of the medical technology company's stock valued at $25,000 after purchasing an additional 255 shares in the last quarter. Financial Gravity Asset Management Inc. boosted its position in shares of Medtronic by 317.0% during the third quarter. Financial Gravity Asset Management Inc. now owns 367 shares of the medical technology company's stock valued at $29,000 after purchasing an additional 279 shares in the last quarter. Fairfield Bush & CO. bought a new stake in shares of Medtronic during the second quarter valued at approximately $32,000. Finally, Certified Advisory Corp bought a new stake in shares of Medtronic during the first quarter valued at approximately $31,000. 82.06% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, EVP Michael Marinaro sold 854 shares of Medtronic stock in a transaction on Monday, April 8th. The stock was sold at an average price of $83.14, for a total value of $71,001.56. Following the completion of the sale, the executive vice president now owns 27,925 shares of the company's stock, valued at $2,321,684.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, EVP Michael Marinaro sold 854 shares of Medtronic stock in a transaction on Monday, April 8th. The stock was sold at an average price of $83.14, for a total value of $71,001.56. Following the completion of the sale, the executive vice president now owns 27,925 shares of the company's stock, valued at $2,321,684.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Sean Salmon sold 30,695 shares of Medtronic stock in a transaction on Wednesday, February 21st. The stock was sold at an average price of $85.13, for a total value of $2,613,065.35. Following the completion of the sale, the executive vice president now directly owns 48,289 shares of the company's stock, valued at approximately $4,110,842.57. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.

Medtronic Stock Up 0.1 %

Shares of MDT stock traded up $0.10 during mid-day trading on Monday, hitting $80.23. The company's stock had a trading volume of 6,896,240 shares, compared to its average volume of 6,309,057. Medtronic plc has a 52-week low of $68.84 and a 52-week high of $92.02. The business has a 50-day moving average price of $84.65 and a 200 day moving average price of $81.01. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.71 and a current ratio of 2.30. The stock has a market cap of $106.53 billion, a price-to-earnings ratio of 25.55, a PEG ratio of 2.74 and a beta of 0.76.

Medtronic (NYSE:MDT - Get Free Report) last posted its quarterly earnings results on Tuesday, February 20th. The medical technology company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.04. Medtronic had a return on equity of 13.71% and a net margin of 13.00%. The firm had revenue of $8.09 billion during the quarter, compared to analysts' expectations of $7.95 billion. During the same quarter in the previous year, the business earned $1.30 earnings per share. The company's revenue was up 4.7% on a year-over-year basis. Research analysts predict that Medtronic plc will post 5.2 EPS for the current fiscal year.

Medtronic Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 22nd were issued a $0.69 dividend. This represents a $2.76 annualized dividend and a dividend yield of 3.44%. The ex-dividend date was Thursday, March 21st. Medtronic's payout ratio is currently 87.90%.

Analyst Ratings Changes

Several research firms recently weighed in on MDT. Mizuho lifted their price target on Medtronic from $95.00 to $98.00 and gave the company a "buy" rating in a research report on Wednesday, February 21st. Royal Bank of Canada restated a "sector perform" rating and set a $92.00 price target on shares of Medtronic in a research report on Wednesday, February 21st. Oppenheimer lifted their price objective on Medtronic from $89.00 to $92.00 and gave the company a "market perform" rating in a research note on Wednesday, February 21st. Finally, Truist Financial lifted their price objective on Medtronic from $87.00 to $90.00 and gave the company a "hold" rating in a research note on Wednesday, February 21st. One analyst has rated the stock with a sell rating, four have given a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $94.91.

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc (NYSE:MDT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.